You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BPX-501

Showing 1 - 25 of 132
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Pavia, Rome, Turin (BPX-501 T cells, rimiducid)

Active, not recruiting
  • Hematologic Malignancy
  • Pavia, Italy
  • +2 more
Jul 10, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Hematologic Malignancies Trial in Houston (BPX-501, AP1903)

Withdrawn
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson Cancer Center
Oct 1, 2020

Leukemia, MDS, Lymphomas Trial (rivogenlecleucel, Rimiducid)

Withdrawn
  • Leukemia
  • +4 more
  • (no location specified)
Oct 1, 2020

Hurler Syndrome, Inherited Metabolic Disorder, Lysosomal Storage Disorder Trial in Los Angeles, Palo Alto (rivogenlecleucel,

No longer available
  • Hurler Syndrome
  • +4 more
  • Los Angeles, California
  • +1 more
Oct 1, 2020

Acute Myeloid Leukemia, MDS Trial in Nashville, San Antonio (biological, drug, procedure)

Terminated
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • rivogenlecleucel
  • +3 more
  • Nashville, Tennessee
  • +1 more
Nov 11, 2020

Acute Bilineal Leukemia, Myelodysplastic/Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor, Unclassifiable

Withdrawn
  • Acute Bilineal Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 12, 2020

Adalimumab Trial in Cypress, South Miami, Salt Lake City (ABP 501-HCF, ABP 501-LCF)

Completed
  • Adalimumab
  • ABP 501-HCF
  • ABP 501-LCF
  • Cypress, California
  • +2 more
Jun 9, 2023

Clinical-immunological Features of Anti-NMDAR Encephalitis

Active, not recruiting
  • Anti NMDA Receptor Encephalitis
  • Description of clinical characteristic
  • Lyon, Bron, France
    Hôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
Feb 12, 2023

Type 2 Diabetes Trial in Seongnam-si (CKD-383, CKD-501, D745, D150, D029)

Not yet recruiting
  • Type 2 Diabetes
  • Seongnam-si, Bundang, Korea, Republic of
    CHA Bundang Medical Center, CHA University
Jun 1, 2023

Type 2 Diabetes Trial in Seongnam-si (CKD-383, CKD-501, D744, D150)

Not yet recruiting
  • Type 2 Diabetes
  • Seongnam-si, Bundang, Korea, Republic of
    CHA Bundang Medical Center, CHA University
Apr 17, 2023

HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

Recruiting
  • HER-2 Gene Amplification
  • +4 more
  • chimeric antigen receptor (CAR) T cell therapy
  • Duarte, California
  • +6 more
Aug 10, 2022

Amyotrophic Lateral Sclerosis Trial in Boston, Hackensack (RAPA-501 Autologous T cells)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • RAPA-501 Autologous T cells
  • Boston, Massachusetts
  • +1 more
Mar 1, 2022

Healthy Volunteers Trial (ABP 501, Adalimumab)

Completed
  • Healthy Volunteers
  • (no location specified)
Aug 9, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

NASH - Nonalcoholic Steatohepatitis Trial in San Antonio (TERN-501, TERN-101, Placebo)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Chandler, Arizona
  • +21 more
Jan 6, 2023

Smoking Trial in Overland Park, Lexington, New York (CERC-501, Placebo)

Completed
  • Smoking
  • Overland Park, Kansas
  • +2 more
May 25, 2022

Cystic Fibrosis Trial in United States (Inhaled AR-501, Inhaled Placebo)

Recruiting
  • Cystic Fibrosis
  • Inhaled AR-501
  • Inhaled Placebo
  • Tucson, Arizona
  • +21 more
Apr 12, 2022

MDD Trial (ANC-501)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Jun 27, 2022

Solid Tumor, Microsatellite Instability, Mismatch Repair Deficiency Trial in Australia (APL-501)

Completed
  • Solid Tumor
  • +3 more
  • Camperdown, New South Wales, Australia
  • +4 more
May 5, 2022

Plaque Psoriasis Trial in Worldwide (Adalimumab, ABP 501)

Completed
  • Plaque Psoriasis
  • Birmingham, Alabama
  • +87 more
Jan 4, 2023

Agitation,Psychomotor, Dementia Trial in United States (Sublingual film containing Dexmedetomidine, Sublingual Placebo Film)

Completed
  • Agitation,Psychomotor
  • Dementia
  • Sublingual film containing Dexmedetomidine
  • Sublingual Placebo Film
  • Homestead, Florida
  • +4 more
Sep 15, 2022

Intertrochanteric Fractures, Femoral Fracture, Femoral Neck Fractures Trial (Artemis Proximal Femoral Nail (PFN) implant)

Not yet recruiting
  • Intertrochanteric Fractures
  • +2 more
  • Artemis Proximal Femoral Nail (PFN) implant
  • (no location specified)
Jan 9, 2023

MDD Trial (NMRA-335140, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Sep 21, 2023

MDD Trial (NMRA-335140, Placebo)

Not yet recruiting
  • Major Depressive Disorder
  • (no location specified)
Sep 21, 2023